Agilent Technologies, Inc. (NYSE:A – Get Free Report) announced a quarterly dividend on Wednesday, May 20th. Investors of record on Tuesday, June 30th will be paid a dividend of 0.255 per share by the medical research company on Wednesday, July 22nd. This represents a c) annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Tuesday, June 30th.
Agilent Technologies has increased its dividend payment by an average of 0.1%per year over the last three years and has raised its dividend annually for the last 9 consecutive years. Agilent Technologies has a payout ratio of 16.9% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Agilent Technologies to earn $6.55 per share next year, which means the company should continue to be able to cover its $1.02 annual dividend with an expected future payout ratio of 15.6%.
Agilent Technologies Price Performance
Shares of A opened at $113.64 on Thursday. The company has a market capitalization of $32.11 billion, a P/E ratio of 25.09, a price-to-earnings-growth ratio of 2.33 and a beta of 1.22. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44. The firm has a 50 day moving average of $114.79 and a 200 day moving average of $129.89. Agilent Technologies has a twelve month low of $107.07 and a twelve month high of $160.27.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of the business. Flynn Zito Capital Management LLC lifted its stake in shares of Agilent Technologies by 3.2% during the 3rd quarter. Flynn Zito Capital Management LLC now owns 2,257 shares of the medical research company’s stock valued at $290,000 after buying an additional 69 shares in the last quarter. Gabelli Funds LLC lifted its stake in shares of Agilent Technologies by 1.1% during the 3rd quarter. Gabelli Funds LLC now owns 6,620 shares of the medical research company’s stock valued at $850,000 after buying an additional 74 shares in the last quarter. Fiduciary Trust Co lifted its stake in shares of Agilent Technologies by 1.6% during the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after buying an additional 77 shares in the last quarter. NorthCrest Asset Manangement LLC lifted its stake in shares of Agilent Technologies by 1.6% during the 4th quarter. NorthCrest Asset Manangement LLC now owns 5,082 shares of the medical research company’s stock valued at $726,000 after buying an additional 79 shares in the last quarter. Finally, Freestone Capital Holdings LLC lifted its stake in shares of Agilent Technologies by 2.0% during the 4th quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company’s stock valued at $574,000 after buying an additional 84 shares in the last quarter.
About Agilent Technologies
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Featured Stories
- Five stocks we like better than Agilent Technologies
- Freight Boom: The Hormuz Blockade Payday
- The Palantir Paradox—Record Numbers and a Stock That Won’t Cooperate
- TJX Companies Fires on All Cylinders With 9% Revenue Growth
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
